Your browser doesn't support javascript.
loading
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer.
Eikesdal, H P; Yndestad, S; Elzawahry, A; Llop-Guevara, A; Gilje, B; Blix, E S; Espelid, H; Lundgren, S; Geisler, J; Vagstad, G; Venizelos, A; Minsaas, L; Leirvaag, B; Gudlaugsson, E G; Vintermyr, O K; Aase, H S; Aas, T; Balmaña, J; Serra, V; Janssen, E A M; Knappskog, S; Lønning, P E.
Afiliação
  • Eikesdal HP; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. Electronic address: hans.eikesdal@uib.no.
  • Yndestad S; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Elzawahry A; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Llop-Guevara A; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
  • Blix ES; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
  • Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway.
  • Lundgren S; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Vagstad G; Department of Oncology, Førde Hospital, Førde, Norway.
  • Venizelos A; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Minsaas L; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Leirvaag B; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Gudlaugsson EG; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
  • Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Aase HS; Department of Radiology, Haukeland University Hospital, Bergen, Norway.
  • Aas T; Department of Surgery, Haukeland University Hospital, Bergen, Norway.
  • Balmaña J; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Serra V; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
  • Knappskog S; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Lønning PE; Department of Oncology, Haukeland University Hospital, Bergen, Norway; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.
Ann Oncol ; 32(2): 240-249, 2021 02.
Article em En | MEDLINE | ID: mdl-33242536
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Ano de publicação: 2021 Tipo de documento: Article